IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.783
AS - Asia 6.617
EU - Europa 4.407
SA - Sud America 1.620
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 5
Totale 33.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.610
SG - Singapore 3.356
UA - Ucraina 1.601
BR - Brasile 1.261
CN - Cina 1.189
DE - Germania 772
FI - Finlandia 667
HK - Hong Kong 641
VN - Vietnam 561
RU - Federazione Russa 331
FR - Francia 260
IE - Irlanda 253
SE - Svezia 180
KR - Corea 161
AR - Argentina 158
TR - Turchia 144
IN - India 129
IT - Italia 106
GB - Regno Unito 98
BD - Bangladesh 97
CA - Canada 76
IQ - Iraq 66
CO - Colombia 50
ZA - Sudafrica 50
EC - Ecuador 48
ID - Indonesia 48
MX - Messico 41
PK - Pakistan 41
VE - Venezuela 30
MA - Marocco 25
ES - Italia 21
PY - Paraguay 20
TN - Tunisia 20
UZ - Uzbekistan 20
CL - Cile 18
NL - Olanda 17
JP - Giappone 16
PE - Perù 15
PL - Polonia 15
UY - Uruguay 15
BE - Belgio 14
EU - Europa 14
SA - Arabia Saudita 14
KZ - Kazakistan 13
IR - Iran 12
JM - Giamaica 12
KE - Kenya 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
MY - Malesia 11
AT - Austria 10
DZ - Algeria 10
JO - Giordania 10
OM - Oman 10
TW - Taiwan 10
PT - Portogallo 9
CR - Costa Rica 8
CH - Svizzera 7
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
BH - Bahrain 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
HU - Ungheria 5
LB - Libano 5
LT - Lituania 5
RS - Serbia 5
HN - Honduras 4
KG - Kirghizistan 4
PA - Panama 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BS - Bahamas 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
IL - Israele 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
CM - Camerun 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
PR - Porto Rico 2
SN - Senegal 2
Totale 33.571
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.298
Fairfield 2.612
Ann Arbor 2.388
Houston 1.876
Ashburn 1.294
Jacksonville 1.187
Seattle 1.006
Singapore 994
Wilmington 927
Cambridge 926
Hong Kong 632
Dearborn 554
Beijing 532
Chandler 528
San Jose 314
Boardman 299
Princeton 266
Dublin 252
Lauterbourg 234
Council Bluffs 213
Ho Chi Minh City 213
Hefei 158
Seoul 151
Los Angeles 150
San Diego 140
Helsinki 131
Hanoi 125
Buffalo 123
Izmir 116
Dallas 108
São Paulo 102
Munich 100
The Dalles 97
New York 62
Ogden 56
Norwalk 49
Redondo Beach 46
Rio de Janeiro 44
Ottawa 42
Des Moines 41
San Mateo 35
Belo Horizonte 31
Haiphong 31
Nanjing 30
Santa Clara 30
Grafing 27
Frankfurt am Main 26
Baghdad 25
Brasília 25
Nuremberg 24
Porto Alegre 24
Johannesburg 22
Kunming 22
Udine 21
Orem 20
Campinas 18
Chicago 18
Da Nang 18
Guangzhou 18
Mumbai 18
Quito 18
Dhaka 17
Tashkent 17
Curitiba 16
Guayaquil 16
Nanchang 16
Salvador 16
Denver 15
Bogotá 14
Buenos Aires 14
Ribeirão Preto 14
Tokyo 14
Warsaw 14
Charlotte 13
Hải Dương 13
Jinan 13
Medellín 12
Phoenix 12
Andover 11
Can Tho 11
Guarulhos 11
Hull 11
Mexico City 11
Sorocaba 11
São José do Rio Preto 11
Toronto 11
Atlanta 10
Brussels 10
Chennai 10
Lahore 10
Leawood 10
Lima 10
Nairobi 10
Ninh Bình 10
Osasco 10
Santo André 10
Thái Bình 10
Wuhan 10
Biên Hòa 9
Boston 9
Totale 23.359
Salva come PNG Salva come JPEG
Nome #
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 250
Possible role of oxidative stress in the pathogenesis of hypertension. 228
Oxidative stress and diabetes-associated complications. 215
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 202
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 190
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 182
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 181
Intra-arterial iloprost for limb ischaemia. 181
The metabolic syndrome--a postprandial disease? 179
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 178
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 175
Acute hyperglycaemia and oxidative stress generation. 170
Does a common mechanism induce diverse complications of diabetes? 169
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 169
Antioxidant therapy in diabetic complications: what is new? 166
Total radical-trapping antioxidant parameter in NIDDM patients. 165
D-lysine and non-enzymatic glycation. 164
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 164
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 164
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 163
Pregnancy as environmental factor precipitating IDDM. 161
Antioxidant anti-inflammatory treatment in type 2 diabetes. 161
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 160
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 160
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 159
Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human Umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production 159
Aspirin and non-enzymatic glycation. 157
Mean red blood cell volume, narcotic addiction, and glucose tolerance 157
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 157
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 157
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 156
Congestive heart failure and cognitive impairment in the elderly. 156
Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. 155
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 154
Increased glycosylated proteins in opiate addicts. 154
Guideline for management of postmeal glucose. 154
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 154
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 153
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 153
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 153
Meal-generated oxidative stress in type 2 diabetic patients 152
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 152
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 151
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 151
Detection of nitrotyrosine in the diabetic plasma: evidence for oxidative stress 151
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 151
Postprandial glucose regulation: new data and new implications. 151
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 150
Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. 150
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 150
Point: postprandial glucose levels are a clinically important treatment target. 150
Non-enzymatic glycosylation reduces antithrombin III activity 150
Impaired glucose metabolism in heroin and methadone users. 149
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 149
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. 149
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 149
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 148
Evidence for a reduced heparin cofactor II biological activity in diabetes. 147
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress 147
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 147
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 147
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 146
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 146
The combined insulin and sulfonylurea therapy in diabetes of elderly people. 146
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 146
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. 146
How do we define cure of diabetes? 146
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 146
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 145
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 145
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 145
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia 144
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 144
Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. 144
Glucose metabolism and hyperglycemia. 144
Impaired insulin response to glucose but not to arginine in heroin addicts. 143
Tolrestat in the primary prevention of diabetic neuropathy. 143
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 143
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 143
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 143
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 142
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 142
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. 141
Oxidative stress in diabetes. 141
Effects of gliclazide beyond metabolic control. 141
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 141
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. 141
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 141
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 141
Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. 139
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 139
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 139
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 139
Opiate addict as diabetic patient? 139
Pathogenetic loop between diabetes and cell senescence. 138
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 137
Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. 137
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 137
Antithrombin III and glycosylated hemoglobin in diabetic subjects 136
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. 136
Totale 15.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.937
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/20254.209 46 292 49 81 50 159 227 192 415 603 640 1.455
2025/20266.828 333 764 710 983 859 521 718 258 390 683 378 231
2026/2027117 117 0 0 0 0 0 0 0 0 0 0 0
Totale 33.642